Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Virchows Archiv : an International Journal of Pathology|July 18, 2023
Prognostic value and clinicopathological roles of the tumor immune microenvironment in salivary duct carcinomaHideaki Hirai, Masato Nakaguro, Yuichiro Tada, et al.
Histopathology|July 12, 2018
The high expression of FOXA1 is correlated with a favourable prognosis in salivary duct carcinomas: a study of 142 casesMakoto Urano, Hideaki Hirai, Yuichiro Tada, et al.
The American Journal of Surgical Pathology|November 26, 2019
Prognostic Implication of Histopathologic Indicators in Salivary Duct Carcinoma: Proposal of a Novel Histologic Risk Stratification ModelMasato Nakaguro, Yukiko Sato, Yuichiro Tada, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|July 26, 2022
Salivary gland polymorphous adenocarcinoma: Clinicopathological features and gene alterations in 36 Japanese patientsMasahiro Fukumura, Kenichiro Ishibashi, Masato Nakaguro, et al.
Virchows Archiv : an International Journal of Pathology|July 23, 2024
The clinicopathological and prognostic significance of autonomic nerves in salivary duct carcinomaManami Kajiwara, Hideaki Takahashi, Masato Nakaguro, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 9, 2025
Cytoplasmic p53 Immunostaining in Salivary Duct Carcinoma: A Poor Prognostic Factor Associated With Characteristic TP53 VariantsYoshitaka Utsumi, Masato Nakaguro, Daisuke Kawakita, et al.
Oncotarget|February 9, 2018
Prognostic and histogenetic roles of gene alteration and the expression of key potentially actionable targets in salivary duct carcinomasTomotaka Shimura, Yuichiro Tada, Hideaki Hirai, et al.
Virchows Archiv : an International Journal of Pathology|February 28, 2020
The clinicopathological significance of the adipophilin and fatty acid synthase expression in salivary duct carcinomaHideaki Hirai, Yuichiro Tada, Masato Nakaguro, et al.
Frontiers in Oncology|February 21, 2022
The Role of the EZH2 and H3K27me3 Expression as a Predictor of Clinical Outcomes in Salivary Duct Carcinoma Patients: A Large-Series Study With Emphasis on the Relevance to the Combined Androgen Blockade and HER2-Targeted TherapyNatsuki Saigusa, Hideaki Hirai, Yuichiro Tada, et al.
Oral Oncology|April 19, 2025
The impact of HER2-Low expression in salivary duct carcinoma: Clinicopathologic features, survival outcomes, and association with androgen receptor-targeted therapySatoshi Kano, Daisuke Kawakita, Yoshitaka Honma, et al.
Pageof 10